Physica TT Tibial Plate Prospective Study
A Post Market, Prospective Clinical Study Evaluating Clinical and Radiographic Outcomes of Patients Undergoing Total Knee Arthroplasty with Physica TT Tibial Plate
1 other identifier
observational
142
0 countries
N/A
Brief Summary
This prospective clinical study aims at evaluating clinical, radiographic, patient-reported outcomes of total knee arthroplasty with Physica TT Tibial Plate over 2 years after surgery, in order to assess the performance and safety of the devices. Short-term survivorship of the implant and the incidence of early complications are evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2025
CompletedFirst Posted
Study publicly available on registry
February 17, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
February 17, 2025
February 1, 2025
3.6 years
February 11, 2025
February 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Knee Society Score from preoperative to 2 years after surgery
0-100 scale. Scores rating from 80 to 100 are considered excellent, between 70 and 79 good, between 60 and 69 fair, and less than 60 poor
From preoperative to 2 years after surgery
Secondary Outcomes (5)
Change in Oxford Knee Score
From preoperative to 2 years after surgery
Change in Range of Motion
From preoperative to 2 years after surgery
Radiographic implant evaluation and stability assessment
From preoperative to 2 years after surgery
Incidence, type and severity of Adverse Device Effects (ADE) and Serious Adverse Device Effects (SADE)
From preoperative to 2 years after surgery
Implant survival rate
From preoperative to 2 years after surgery
Study Arms (1)
Physica TT Tibial Plate
Total knee arthroplasty with Physica TT Tibial Plate
Eligibility Criteria
General population of subjects requiring a primary TKR with a diagnosis of painful primary or secondary osteoartrithis not responding to other conservative treatments, after the review of medical history and the radiographic evaluation of the affected knee.
You may qualify if:
- Patient requiring a total knee arthroplasty (TKA) and suitable for receiving Physica TT Tibial Plate;
- Age ≥ 18 years old;
- Candidate for primary total knee replacement when clinical indications based on physical examination and medical history include one or more of the following conditions:
- Non-inflammatory degenerative joint disease such as knee osteoarthritis, post traumatic knee arthritis;
- Inflammatory degenerative joint disease such as rheumatoid arthritis;
- Patient has well-preserved and well-functioning collateral ligaments
- Patient is able to understand the conditions of the study, is willing and able to follow all prescribed rehabilitation as well as willing to perform all scheduled follow-up visits;
- Patient has signed the study-specific Informed Consent Form prior to study activities
You may not qualify if:
- Patient is affected by one or more of the conditions that are stated as Physica contraindications for use, which are:
- Severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function.
- Any active or suspected infection (local or systemic) or previous history of infection that may affect the prosthetic joint.
- Significant bone loss on femoral or tibial joint side.
- Known incompatibility or allergy to the product materials, and/or metal hypersensitivity to implant materials.
- Septicaemia.
- Persistent acute or chronic osteomyelitis.
- Open epiphyses (immature patient with active bone growth).
- Necrotic bone
- Arterial vascular insufficiency or nerve diseases of the lower limbs severe enough to interfere with the study evaluation.
- Compromised bone stock due to disease, infection or prior implantation that cannot provide adequate support and/or fixation to the prosthesis.
- Systemic or metabolic disorders leading to progressive bone deterioration, which may impair fixation and stability of the implant.
- Any concomitant disease and dependency that might affect the performance of the implanted prosthesis.
- Important osteoporosis, haemophilic disease.
- Internistic problems with high risk for surgery.
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2025
First Posted
February 17, 2025
Study Start
May 1, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
February 17, 2025
Record last verified: 2025-02